-
-
Overview
-
1 and v3 integrin signalling modulator.
VnP-16 is a peptide corresponding to residues 270-281 of human vitronectin, which exerts an anti-osteoporotic effect via 1 and v3 integrin signalling. VnP-16 promotes bone formation by accelerating osteoblast differentiation through direct interaction with 1 integrin followed by FAK activation, while inhibiting bone resorption through restraint of JNK-c-Fos-NFATc1 induced osteoclast differentiation and v3 integrin-c-Src-PYK2 mediated resorption. In a mouse model of estrogen deficiency induced osteoporosis, VnP-16 reverses ovariectomy induced bone loss by increasing osteoblast differentiation and promoting bone formation, while decreasing osteoclastogenesis and inhibiting bone resorption.
Please contact us for availability.Please contact us at for specific academic pricing.
-
- Properties
-
Overview